Clinical evaluation of dried blood spots for the determination of ribociclib blood levels
- Conditions
- Borstkanker10006291
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1. Age * 18 years;
2. Able to understand the written information and able to give informed consent;
3. Treated with ribociclib;
4. Able and willing to undergo a finger prick for dried blood spot sampling.
Exclusion Criteria
Unable to draw blood for study purposes.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>To develop and validate a dried blood spot (DBS) method for determination of<br /><br>ribociclib.</p><br>
- Secondary Outcome Measures
Name Time Method <p>To characterize the pharmacokinetics of ribociclib.</p><br>